Replimune Group Inc
REPLHealthcare|Biotechnology|USA
$10.99
-0.12 (-1.08%)
Tangible Book
$2.01
Earnings Power
$1.15
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (123)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sarchi Christopher | Chief Commercial Officer | 2026-06-01 | SELL | 12,000 | $9.24 | $110.9K |
| Schwendenman Andrew | Chief Accounting Officer | 2026-05-18 | SELL | 7,894 | $5.08 | $40.1K |
| Sarchi Christopher | Chief Commercial Officer | 2026-05-18 | SELL | 8,626 | $5.08 | $43.8K |
| Astley-Sparke Philip | Director | 2026-05-18 | SELL | 17,657 | $5.08 | $89.7K |
| Patel Sushil | CEO | 2026-05-18 | SELL | 37,324 | $5.08 | $189.6K |
| Hill Emily Luisa | CFO | 2026-05-18 | SELL | 7,812 | $5.08 | $39.7K |
| Xynos Konstantinos | Chief Medical Officer | 2026-05-18 | SELL | 14,023 | $5.08 | $71.2K |
| Sarchi Christopher | Chief Commercial Officer | 2026-04-02 | SELL | 6,500 | $8.01 | $52.1K |
| Dhingra Kapil | Director | 2025-12-09 | SELL | 3,169 | $10.4 | $33K |
| Patel Sushil | CEO | 2025-12-02 | SELL | 10,000 | $11.13 | $111.3K |
| Xynos Konstantinos | Chief Medical Officer | 2025-11-17 | SELL | 7,248 | $9.1 | $66K |
| Hill Emily Luisa | CFO | 2025-08-15 | SELL | 9,154 | $5.37 | $49.2K |
| Astley-Sparke Philip | Director | 2025-05-20 | SELL | 32,279 | $8.06 | $260.2K |
| Xynos Konstantinos | Chief Medical Officer | 2025-05-20 | SELL | 7,952 | $8.06 | $64.1K |
| Schwendenman Andrew | Chief Accounting Officer | 2025-05-20 | SELL | 3,287 | $8.05 | $26.5K |
| Patel Sushil | CEO | 2025-05-20 | SELL | 25,105 | $8.06 | $202.3K |
| Hill Emily Luisa | CFO | 2025-05-20 | SELL | 2,535 | $8.05 | $20.4K |
| Sarchi Christopher | Chief Commercial Officer | 2025-05-20 | SELL | 3,749 | $8.05 | $30.2K |
| Patel Sushil | CEO | 2024-12-16 | SELL | 10,000 | $12.42 | $124.2K |
| Xynos Konstantinos | Chief Medical Officer | 2024-11-18 | SELL | 7,246 | $10.78 | $78.1K |
| Sarchi Christopher | Chief Commercial Officer | 2024-11-18 | SELL | 5,207 | $10.78 | $56.1K |
| Hill Emily Luisa | CFO | 2024-08-16 | SELL | 8,938 | $10.18 | $91K |
| Xynos Konstantinos | Chief Medical Officer | 2024-06-07 | SELL | 15,881 | $7.5 | $119.1K |
| Coffin Robert | Director | 2024-05-16 | SELL | 11,464 | $6.47 | $74.2K |
| Patel Sushil | CEO | 2024-05-16 | SELL | 20,194 | $6.47 | $130.7K |
| Xynos Konstantinos | Chief Medical Officer | 2024-05-16 | SELL | 6,367 | $6.47 | $41.2K |
| Sarchi Christopher | Chief Commercial Officer | 2024-05-16 | SELL | 2,218 | $6.47 | $14.4K |
| Schwendenman Andrew | Chief Accounting Officer | 2024-05-16 | SELL | 2,298 | $6.47 | $14.9K |
| Love Colin | COO | 2024-05-16 | SELL | 17,615 | $6.47 | $114K |
| Astley-Sparke Philip | Executive Chairman | 2024-05-16 | SELL | 37,928 | $6.47 | $245.4K |
| Xynos Konstantinos | Chief Medical Officer | 2023-11-16 | SELL | 7,313 | $10.92 | $79.9K |
| Sarchi Christopher | Chief Commercial Officer | 2023-11-16 | SELL | 5,255 | $10.92 | $57.4K |
| Esposito Pamela | Chief Business Officer | 2023-09-12 | SELL | 5,658 | $20.01 | $113.2K |
| Esposito Pamela | Chief Business Officer | 2023-08-22 | SELL | 18,600 | $20.01 | $372.2K |
| Esposito Pamela | Chief Business Officer | 2023-08-11 | SELL | 1,400 | $20 | $28K |
| Esposito Pamela | Chief Business Officer | 2023-07-10 | SELL | 20,000 | $21.58 | $431.6K |
| Lewis Tanya | Chief Dev. Op. Officer | 2023-06-13 | SELL | 12,860 | $24.06 | $309.4K |
| Patel Sushil | Chief Strategy Officer | 2023-06-13 | SELL | 5,698 | $24.04 | $137K |
| Patel Sushil | Chief Strategy Officer | 2023-05-16 | SELL | 15,575 | $18.05 | $281.1K |
| Coffin Robert | President & Chief R&D Officer | 2023-05-16 | SELL | 7,861 | $18.05 | $141.9K |
| Lewis Tanya | Chief Dev. Op. Officer | 2023-05-16 | SELL | 12,207 | $18.05 | $220.3K |
| Love Colin | COO | 2023-05-16 | SELL | 10,775 | $18.05 | $194.5K |
| Franchi Jean M. | CFO | 2023-05-16 | SELL | 11,351 | $18.05 | $204.9K |
| Xynos Konstantinos | Chief Medical Officer | 2023-05-16 | SELL | 771 | $18.05 | $13.9K |
| Esposito Pamela | Chief Business Officer | 2023-05-16 | SELL | 5,966 | $18.05 | $107.7K |
| Astley-Sparke Philip | CEO | 2023-05-16 | SELL | 17,902 | $18.05 | $323.1K |
| Esposito Pamela | Chief Business Officer | 2022-12-09 | SELL | 15,000 | $25.03 | $375.5K |
| Love Colin | COO | 2022-05-16 | SELL | 6,324 | $14.59 | $92.3K |
| Esposito Pamela | Chief Business Officer | 2022-05-16 | SELL | 3,507 | $14.59 | $51.2K |
| Franchi Jean M. | CFO | 2022-05-16 | SELL | 3,436 | $14.59 | $50.1K |
| Lewis Tanya | Chief Dev. Op Officer | 2022-05-16 | SELL | 5,473 | $14.59 | $79.9K |
| Patel Sushil | Chief Commercial Officer | 2022-05-16 | SELL | 10,687 | $14.59 | $155.9K |
| Coffin Robert | President & Chief R&D Officer | 2022-05-16 | SELL | 5,737 | $14.59 | $83.7K |
| Astley-Sparke Philip | CEO | 2022-05-16 | SELL | 9,632 | $14.59 | $140.5K |
| Omega Fund IV GP, L.P. | 10% Owner | 2022-03-16 | SELL | 106,500 | $15.55 | $1656.1K |
| Omega Fund IV GP, L.P. | 10% Owner | 2021-11-22 | SELL | 45,424 | $34.58 | $1570.8K |
| Omega Fund IV GP, L.P. | 10% Owner | 2021-11-18 | SELL | 2,594 | $33.5 | $86.9K |
| Omega Fund IV GP, L.P. | 10% Owner | 2021-11-18 | SELL | 2,594 | $33.5 | $86.9K |
| Omega Fund IV GP, L.P. | 10% Owner | 2021-11-15 | SELL | 24,017 | $33.66 | $808.4K |
| Omega Fund IV GP, L.P. | 10% Owner | 2021-11-11 | SELL | 18,290 | $33.61 | $614.7K |
| Omega Fund IV GP, L.P. | 10% Owner | 2021-11-09 | SELL | 11,354 | $33.66 | $382.2K |
| Omega Fund IV GP, L.P. | 10% Owner | 2021-11-05 | SELL | 31,015 | $33.57 | $1041.2K |
| Love Colin | COO | 2021-10-18 | SELL | 30,000 | $30.06 | $901.8K |
| Omega Fund IV GP, L.P. | Director, 10% Owner | 2021-09-23 | SELL | 12,171 | $33.58 | $408.7K |
| Omega Fund IV GP, L.P. | 10% Owner | 2021-09-17 | SELL | 100,000 | $32.99 | $3299K |
| Love Colin | COO | 2021-09-15 | SELL | 30,000 | $31.23 | $936.9K |
| Love Colin | COO | 2021-08-16 | SELL | 30,000 | $29.93 | $897.9K |
| Esposito Pamela | Chief Business Officer | 2021-08-05 | SELL | 30,000 | $35.08 | $1052.4K |
| Esposito Pamela | Chief Business Officer | 2021-07-21 | SELL | 17,400 | $33.14 | $576.6K |
| Esposito Pamela | Chief Business Officer | 2021-07-15 | SELL | 4,600 | $33.37 | $153.5K |
| Love Colin | COO | 2021-07-15 | SELL | 30,000 | $32.02 | $960.6K |
| Coffin Robert | President & Chief R&D Officer | 2021-07-02 | SELL | 7,810 | $40.04 | $312.7K |
| Love Colin | COO | 2021-04-15 | SELL | 30,000 | $30.63 | $918.9K |
| Love Colin | COO | 2021-03-15 | SELL | 30,000 | $33.54 | $1006.2K |
| Love Colin | COO | 2021-02-16 | SELL | 30,000 | $36.32 | $1089.6K |
| Omega Fund IV GP, L.P. | 10% Owner | 2021-02-08 | SELL | 5,249 | $45 | $236.2K |
| Omega Fund IV GP, L.P. | 10% Owner | 2021-01-26 | SELL | 30,350 | $45.42 | $1378.5K |
| Rhodes Jason P | Director | 2021-01-26 | SELL | 5,558 | $46.14 | $256.4K |
| Omega Fund IV GP, L.P. | 10% Owner | 2021-01-22 | SELL | 11,359 | $45.04 | $511.6K |
| Coffin Robert | President & Chief R&D Officer | 2021-01-22 | SELL | 60,000 | $44.43 | $2665.8K |
| Astley-Sparke Philip | CEO | 2021-01-19 | SELL | 50,000 | $43.76 | $2188K |
| Esposito Pamela | Chief Business Officer | 2021-01-19 | SELL | 55,000 | $43.99 | $2419.5K |
| Love Colin | COO | 2021-01-19 | SELL | 30,000 | $43.24 | $1297.2K |
| Esposito Pamela | Chief Business Officer | 2021-01-19 | SELL | 55,000 | $43.99 | $2419.5K |
| Omega Fund IV GP, L.P. | 10% Owner | 2021-01-15 | SELL | 19,580 | $45.1 | $883.1K |
| Franchi Jean M. | CFO | 2021-01-14 | SELL | 15,000 | $44.53 | $668K |
| Coffin Robert | President & Chief R&D Officer | 2020-12-22 | SELL | 220,000 | $40.04 | $8808.8K |
| Rhodes Jason P | Director | 2020-12-18 | SELL | 4,319 | $41.95 | $181.2K |
| Rhodes Jason P | Director | 2020-12-17 | SELL | 65,029 | $42.28 | $2749.4K |
| Rhodes Jason P | Director | 2020-12-14 | SELL | 103,686 | $43.35 | $4494.8K |
| Franchi Jean M. | CFO | 2020-12-14 | SELL | 25,000 | $43.45 | $1086.3K |
| Astley-Sparke Philip | CEO | 2020-12-10 | SELL | 50,000 | $43.4 | $2170K |
| Rhodes Jason P | Director | 2020-12-09 | SELL | 217,362 | $45.92 | $9981.3K |
| Love Colin | COO | 2020-12-09 | SELL | 30,000 | $43.75 | $1312.5K |
| SLATTERY JOSEPH P | Director | 2020-12-08 | SELL | 5,200 | $46 | $239.2K |
| Dhingra Kapil | Director | 2020-12-07 | SELL | 40,000 | $45.56 | $1822.4K |
| Love Colin | COO | 2020-11-16 | SELL | 15,000 | $44.91 | $673.7K |
| Esposito Pamela | Chief Business Officer | 2020-10-14 | SELL | 16,000 | $32.9 | $526.4K |
| Love Colin | COO | 2020-09-15 | SELL | 15,000 | $23.97 | $359.6K |
| Esposito Pamela | Chief Business Officer | 2020-08-31 | SELL | 5,000 | $27.05 | $135.3K |
| Love Colin | COO | 2020-08-17 | SELL | 15,000 | $23.44 | $351.6K |
| Coffin Robert | President & Chief R&D Officer | 2020-07-09 | SELL | 169,750 | $22.13 | $3756.6K |
| Coffin Robert | Pres & Chief Res & Dev Officer | 2020-02-20 | SELL | 24,250 | $17.04 | $413.2K |
| Coffin Robert | Pres & Chief Res & Dev Officer | 2020-02-12 | SELL | 48,500 | $17.04 | $826.4K |
| Rhodes Jason P | Director | 2019-11-18 | BUY | 1,100,000 | $13.61 | $14971K |
| Omega Fund IV GP, L.P. | 10% Owner | 2019-11-18 | BUY | 220,000 | $13.61 | $2994.2K |
| Love Colin | COO | 2019-11-06 | SELL | 22,500 | $17.01 | $382.7K |
| Astley-Sparke Philip | Executive Chairman | 2019-11-06 | SELL | 29,000 | $17.01 | $493.3K |
| Coffin Robert | President and CEO | 2019-11-06 | SELL | 48,500 | $17.01 | $825K |
| Astley-Sparke Philip | Executive Chairman | 2019-11-04 | SELL | 29,000 | $17.03 | $493.9K |
| Love Colin | COO | 2019-11-04 | SELL | 22,500 | $17.03 | $383.2K |
| Coffin Robert | President and CEO | 2019-11-04 | SELL | 48,500 | $17.03 | $826K |
| Coffin Robert | President and CEO | 2019-10-31 | SELL | 24,250 | $17 | $412.3K |
| Astley-Sparke Philip | Executive Chairman | 2019-10-31 | SELL | 14,500 | $17 | $246.5K |
| Love Colin | COO | 2019-10-31 | SELL | 11,250 | $17 | $191.3K |
| Astley-Sparke Philip | Executive Chairman | 2019-09-23 | SELL | 14,500 | $17.05 | $247.2K |
| Love Colin | COO | 2019-09-23 | SELL | 11,250 | $17.05 | $191.8K |
| Coffin Robert | President and CEO | 2019-09-23 | SELL | 24,250 | $17.05 | $413.5K |
| Slootweg Hugo Alexander | Director, 10% Owner | 2018-07-24 | BUY | 133,333 | $15 | $2000K |
| SLATTERY JOSEPH P | Director | 2018-07-24 | BUY | 6,667 | $15 | $100K |
| Forbion Capital Fund III Coope | 10% Owner | 2018-07-24 | BUY | 133,333 | $15 | $2000K |
| Omega Fund IV GP, L.P. | 10% Owner | 2018-07-24 | BUY | 266,667 | $15 | $4000K |
| Bain Capital Life Sciences Inv | 10% Owner | 2018-07-24 | BUY | 500,000 | $15 | $7500K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked